| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Medicine |
From the Whitaker Cardiovascular Institute (C.S., H.M., E.R., A.B., K.W.), Boston University Medical Center, Boston, Mass; and the Department of Medicine (T.F.), Molecular Cardiology Research Institute, Tufts-New England Medical Center, Boston, Mass.
Correspondence to Kenneth Walsh, PhD, Molecular Cardiology/Whitaker Cardiovascular Institute, Boston University School of Medicine, 715 Albany St, W611, Boston, MA 02118. E-mail kxwalsh{at}bu.edu
Glycogen-Synthase Kinase 3ß (GSK3ß) has been shown to function as a nodal point of converging signaling pathways in endothelial cells to regulate vessel growth, but the signaling mechanisms downstream from GSK3ß have not been identified. Here, we show that ß-catenin is an important downstream target for GSK3ß action in angiogenesis and dissect the signal transduction pathways involved in the angiogenic phenotype. Transduction of human umbilical vein endothelial cells (HUVECs) with a kinase-mutant form of the enzyme (KM-GSK3ß) increased cytosolic ß-catenin levels, whereas constitutively active GSK3ß (S9A-GSK3ß) reduced ß-catenin levels. Lymphoid enhancer factor/T-cell factor promoter activity was upregulated by KM-GSK3ß and diminished by S9A-GSK3ß, whereas manipulation of Akt signaling had no effect on this parameter. ß-Catenin transduction induced capillary formation in a Matrigel-plug assay in vivo and promoted endothelial cell differentiation into network structures on Matrigel-coated plates in vitro. ß-Catenin activated the expression of vascular endothelial growth factor (VEGF)-A and VEGF-C in endothelial cells, and these effects were mediated at the levels of protein, mRNA, and promoter activity. Consistent with these data, ß-catenin increased the phosphorylation of the VEGF receptor 2 (VEGF-R2) and promoted its association with PI3-kinase, leading to a dose-dependent activation of the serinethreonine kinase Akt. Inhibition of PI3-kinase or Akt signaling led to a significant reduction in the pro-angiogenic activity of ß-catenin. Collectively, these data show that the growth factorPI3-kinaseAkt axis functions downstream of GSK3ß/ß-catenin signaling in endothelial cells to promote angiogenesis.
Key Words: ß-catenin Akt endothelial cells vacular endothelial growth factor VEGF receptor 2 angiogenesis
This article has been cited by other articles:
![]() |
L. Roy, C. A. McDonald, C. Jiang, D. Maroni, A. J. Zeleznik, T. A. Wyatt, X. Hou, and J. S. Davis Convergence of 3',5'-Cyclic Adenosine 5'-Monophosphate/Protein Kinase A and Glycogen Synthase Kinase-3{beta}/{beta}-Catenin Signaling in Corpus Luteum Progesterone Synthesis Endocrinology, November 1, 2009; 150(11): 5036 - 5045. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-H. Yang, J.-Y. Yoon, S.-H. Lee, V. Bryja, E. R. Andersson, E. Arenas, Y.-G. Kwon, and K.-Y. Choi Wnt5a Is Required for Endothelial Differentiation of Embryonic Stem Cells and Vascularization via Pathways Involving Both Wnt/{beta}-Catenin and Protein Kinase C{alpha} Circ. Res., February 13, 2009; 104(3): 372 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guo, K. Arai, M. F. Stins, D.-M. Chuang, and E. H. Lo Lithium Upregulates Vascular Endothelial Growth Factor in Brain Endothelial Cells and Astrocytes Stroke, February 1, 2009; 40(2): 652 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Yao, H. Yin, B. Shen, R. S. Smith Jr, Y. Liu, L. Gao, L. Chao, and J. Chao Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3{beta} pathway Cardiovasc Res, December 1, 2008; 80(3): 354 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J.G. Horrevoets Kallikrein teams up with GSK-3{beta} in heart failure prevention Cardiovasc Res, December 1, 2008; 80(3): 328 - 329. [Full Text] [PDF] |
||||
![]() |
C. M.L. Beckers, J. J. Garcia-Vallejo, V. W.M. van Hinsbergh, and G. P. van Nieuw Amerongen Nuclear targeting of {beta}-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction Cardiovasc Res, September 1, 2008; 79(4): 679 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Joshi, D. Ivanov, M. Philippova, P. Erne, and T. J. Resink Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3{beta} in endothelial cells FASEB J, October 1, 2007; 21(12): 3083 - 3095. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Hsu, H.-C. Chang, and W.-C. Hung HER-2/neu transcriptionally activates Jab1 expression via the AKT/{beta}-catenin pathway in breast cancer cells Endocr. Relat. Cancer, September 1, 2007; 14(3): 655 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Barbieri and B. B. Weksler Tobacco smoke cooperates with interleukin-1{beta} to alter {beta}-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo FASEB J, June 1, 2007; 21(8): 1831 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, J. B. Gilner, V. L. Bautch, D.-Z. Wang, B. J. Wainwright, S. L. Kirby, and C. Patterson Wnt2 Coordinates the Commitment of Mesoderm to Hematopoietic, Endothelial, and Cardiac Lineages in Embryoid Bodies J. Biol. Chem., January 5, 2007; 282(1): 782 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shiojima and K. Walsh Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway Genes & Dev., December 15, 2006; 20(24): 3347 - 3365. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Leung, Y. L. Pon, R. N. S. Wong, and A. S. T. Wong Ginsenoside-Rg1 Induces Vascular Endothelial Growth Factor Expression through the Glucocorticoid Receptor-related Phosphatidylinositol 3-Kinase/Akt and beta-Catenin/T-cell Factor-dependent Pathway in Human Endothelial Cells J. Biol. Chem., November 24, 2006; 281(47): 36280 - 36288. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Hahn, H.-J. Cho, J.-W. Bae, H.-S. Yuk, K.-i. Kim, K.-W. Park, B.-K. Koo, I.-H. Chae, C.-S. Shin, B.-H. Oh, et al. beta-Catenin Overexpression Reduces Myocardial Infarct Size through Differential Effects on Cardiomyocytes and Cardiac Fibroblasts J. Biol. Chem., October 13, 2006; 281(41): 30979 - 30989. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Arvisais, A. Romanelli, X. Hou, and J. S. Davis AKT-independent Phosphorylation of TSC2 and Activation of mTOR and Ribosomal Protein S6 Kinase Signaling by Prostaglandin F2{alpha} J. Biol. Chem., September 15, 2006; 281(37): 26904 - 26913. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Rocnik, P. Liu, K. Sato, K. Walsh, and C. Vaziri The Novel SPARC Family Member SMOC-2 Potentiates Angiogenic Growth Factor Activity J. Biol. Chem., August 11, 2006; 281(32): 22855 - 22864. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liebner, U. Cavallaro, and E. Dejana The Multiple Languages of Endothelial Cell-to-Cell Communication Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1431 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. H. Masckauchan and J. Kitajewski Wnt/Frizzled Signaling in the Vasculature: New Angiogenic Factors in Sight Physiology, June 1, 2006; 21(3): 181 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Voelkel, R. W. Vandivier, and R. M. Tuder Vascular endothelial growth factor in the lung Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L209 - L221. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Izumi, S. Kim-Mitsuyama, M. Yoshiyama, T. Omura, M. Shiota, A. Matsuzawa, T. Yukimura, T. Murohara, M. Takeya, H. Ichijo, et al. Important Role of Apoptosis Signal-Regulating Kinase 1 in Ischemia-Induced Angiogenesis Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1877 - 1883. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |